Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients

The American Journal of Medicine

Volumn 76, Issue 3 PART 1, 1984, Pages 134-141

  Condie, Richard M ^a   O'Reilly, Richard J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; INTERSTITIAL PNEUMONIA; PROPHYLAXIS; RESPIRATORY SYSTEM;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMAN; IMMUNE SERA; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; INFUSIONS, PARENTERAL; PULMONARY FIBROSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021281394     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(84)90332-2     Document Type: Article

References (44)

1. Early infections in kidney, heart, and liver transplant recipients on cyclosporine
2. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation
3. A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts
4. Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation
5. Treatment of cytomegalovirus pneumonia after marrow transplantation with combined vibarabine and human leukocyte Interferon
6. Effect of adsenine arabinoside on cytomegalovirus infections
7. Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease
8. Acyclovir prophylaxis of herpes-simplex virus infections
9. Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor
10. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation
11. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants
12. Treatment of life-threatening infections in renal transplant recipients with high dose intravenous human IgG
13. Prophylaxis of cytomegalovirus infection in bone marrow transplant recipients by hyperimmune cytomegalovirus gamma-globulin
14. A randomized trial of intravenous, hyperimmune globulin for the prevention of cytomegalovirus infections following marrow transplantation: preliminary results
15. Cytomegalovirus immune plasma in bone marrow transplant recipients
16. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation
17. Hyperimmune immunoglobulin for cytomegalovirus infections
18. Preparation and intravenous use of undenatured human IgG
19. Microplate enzyme immunoassays for the immunodiagnosis of virus infections
20. Hyperfractionated total body irradiation for bone marrow transplantation: I. Early results in leukemia patients
21. Reconstruction in severe combined immune deficiency by transplantation of marrow from an unrelated donor
22. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts
23. The pathology of the graft-versus-host reaction in adults receiving bone marrow transplants
24. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A matched sibling donors
25. Resistance to intracerebral challenge in mice immunized against herpes simplex virus
26. The action of human immunoglobulins in experimental herpes infection in the newborn rat
27. Passive immunization against varicella-zoster infections and other modes of therapy
28. Varicella pneumonia in adults
29. Seroepidemiologic survey of varicella: value of specific antibody test
30. Effect of immunization of mothers on cytomegalovirus infection in suckling mice
31. Protective effect of early serum from mice after cytomegalovirus infection
32. Hypogammaglobulinemia with thymoma, and probable pulmonary infection with cytomegalovirus
33. Cytomegalic inclusion disease in the gastro-intestinal tract of adults
34. Letter to the editor
35. Congenital cytomegalovirus infection outcome for the subsequent sibling
36. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections
37. Treatment of cytomegalovirus pneumonitis with hyperimmune plasma
38. Seven years experience with anti-lymphoblast globulin for renal transplantation from cadaver donors
39. Distribution of virus antibody activity among human IgG subclasses
40. Cytomegalovirus: pathogenicity, immunology, and vaccine initiatives